# Marshall Ethanolization, Pulmonary Vein Isolation and Line Completion for Ablation of Persistent Atrial Fibrillation

> **NCT04681872** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 262 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **PROCEDURE:** Destruction of Marshall bundles
- **PROCEDURE:** Pulmonary veins isolation
- **PROCEDURE:** Linear ablation in the left and right atria

## Key facts

- **NCT ID:** NCT04681872
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-20
- **Primary completion:** 2027-09-20
- **Final completion:** 2027-09-20
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04681872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04681872, "Marshall Ethanolization, Pulmonary Vein Isolation and Line Completion for Ablation of Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04681872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*